Horton's Temporal Arteritis: Giant Vasculitis, NF-kB and Ginger

Horton's disease (giant cell arteritis or temporal arteritis) is the most common primary vasculitis of the large vessels after the age of 50. It mainly affects the temporal and ophthalmic arteries and branches of the aorta. Its dreaded complication: sudden blindness, sometimes bilateral, due to occlusion of the ophthalmic artery. The first-line treatment remains high-dose corticosteroid therapy — but side effects in the long term are considerable.

Pathophysiology: NF-kB and Dendritic Cell Activation

Horton's disease is a transmural granulomatous vasculitis involving:

• Vascular dendritic cells (vDC): activate NF-kB upon contact with antigens not yet identified in the arterial wall → recruitment of CD4+ T lymphocytes
• T helper Th1 and Th17 lymphocytes: produce IFN-γ (Th1) and IL-17A (Th17) → activation of macrophages and giant cells
• IL-6 (via NF-kB): central cytokine — biological marker of the disease (elevated ESR and CRP) and inducer of the Th17 phenotype
• VEGF (Vascular Endothelial Growth Factor): produced by NF-kB-activated macrophages → abnormal neovascularization → paradoxical ischemia
• Multinucleated giant cells: fusion of activated macrophages → core of the granulomatous lesion

Gingerol in Vasculitis: Relevant Mechanisms

Although there are no specific studies of gingerol in Horton's disease, several mechanisms are relevant:

• Inhibition of NF-kB in endothelial cells: gingerol reduces the expression of adhesion molecules (VCAM-1, ICAM-1) which allow the recruitment of lymphocytes into the vascular wall (Phytotherapy Research, 2018)
• IL-6 inhibition: gingerol suppresses IL-6 production by 40-60% in activated macrophages (Journal of Nutritional Biochemistry, 2016) — which could complement the action of tocilizumab (anti-IL-6R)
• VEGF inhibition: gingerol reduces VEGF expression via suppression of HIF-1α and NF-kB (British Journal of Pharmacology, 2020)
• Anti-Th17 effects: gingerol reduces Th17 cell differentiation by inhibiting STAT3 (Molecular Nutrition & Food Research, 2019)

Position in the Treatment of Horton's Disease

Horton's disease is a therapeutic emergency — never delay corticosteroids. INTI does not replace any prescribed treatment. On the other hand, in the maintenance phase under tapering corticosteroid therapy (often 18-24 months), the anti-IL-6 and anti-NF-kB properties of gingerol could help maintain remission and reduce the risk of relapse. This remains to be demonstrated in clinical trials.

Note on GIMBER and corticosteroids

Patients on long-term corticosteroids often have corticosteroid-induced hyperglycemia. GIMBER at 35g of sugar/100ml would aggravate this hyperglycemia. NRTI at 1.19g/100ml is compatible with glycemic monitoring under corticosteroid therapy.

Conclusion

Horton's disease is an NF-kB-dependent vasculitis in which IL-6, VEGF and Th17 cells are the central players — all targets of gingerol. INTI, an artisanal preparation low in sugar, is a supplement anti-inflammatory ginger consistent for patients in remission on corticosteroid therapy. An area where clinical trials are sorely lacking.

Informational article only. Horton's disease is a medical emergency — seek immediate medical attention if it occurs. ginger migraine-cephalees-anti-inflammatory-natural">headache temporalis, amaurosis or claudication of the jaw.